Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer.

Roussidis AE, Theocharis AD, Tzanakakis GN, Karamanos NK.

Curr Med Chem. 2007;14(7):735-43. Review.

PMID:
17346159
2.

A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer.

Tsutsui S, Yasuda K, Suzuki K, Takeuchi H, Nishizaki T, Higashi H, Era S.

Br J Cancer. 2006 Jun 19;94(12):1874-8. Epub 2006 May 23.

3.

Molecular alterations in columnar cell lesions of the breast.

Dabbs DJ, Carter G, Fudge M, Peng Y, Swalsky P, Finkelstein S.

Mod Pathol. 2006 Mar;19(3):344-9.

4.

A mouse model of human breast cancer metastasis to human bone.

Kuperwasser C, Dessain S, Bierbaum BE, Garnet D, Sperandio K, Gauvin GP, Naber SP, Weinberg RA, Rosenblatt M.

Cancer Res. 2005 Jul 15;65(14):6130-8.

5.

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.

Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR.

Am J Surg Pathol. 2005 Jun;29(6):734-46.

PMID:
15897740
6.

Aspiration biopsy of nodular pseudoangiomatous stromal hyperplasia of the breast: clinicopathologic correlates in 10 cases.

Levine PH, Nimeh D, Guth AA, Cangiarella JF.

Diagn Cytopathol. 2005 Jun;32(6):345-50.

PMID:
15880710
7.

Role of stromal-epithelial interactions in hormonal responses.

Cunha GR, Cooke PS, Kurita T.

Arch Histol Cytol. 2004 Dec;67(5):417-34. Review.

8.

Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial.

Kabbinavar FF, Schulz J, McCleod M, Patel T, Hamm JT, Hecht JR, Mass R, Perrou B, Nelson B, Novotny WF.

J Clin Oncol. 2005 Jun 1;23(16):3697-705. Epub 2005 Feb 28.

PMID:
15738537
9.

Tumor-stroma interactions.

Bhowmick NA, Moses HL.

Curr Opin Genet Dev. 2005 Feb;15(1):97-101. Review.

10.

The emerging biological and clinical significance of the columnar cell lesions of the breast.

Siziopikou KP, Gattuso P.

Diagn Cytopathol. 2004 Dec;31(6):369. No abstract available.

PMID:
15540186
11.

Epithelial-stromal interactions in the mouse and human mammary gland in vivo.

Parmar H, Cunha GR.

Endocr Relat Cancer. 2004 Sep;11(3):437-58. Review.

12.

Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays.

Charpin C, Dales JP, Garcia S, Carpentier S, Djemli A, Andrac L, Lavaut MN, Allasia C, Bonnier P.

Clin Cancer Res. 2004 Sep 1;10(17):5815-9.

13.

Fine-needle aspiration cytology of pseudoangiomatous stromal hyperplasia of the breast.

Lui PC, Law BK, Chu WC, Pang LM, Tse GM.

Diagn Cytopathol. 2004 May;30(5):353-5.

PMID:
15108236
14.

Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.

Dales JP, Garcia S, Andrac L, Carpentier S, Ramuz O, Lavaut MN, Allasia C, Bonnier P, Charpin C.

Int J Oncol. 2004 May;24(5):1197-204.

PMID:
15067342
15.

Reconstruction of functionally normal and malignant human breast tissues in mice.

Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4966-71. Epub 2004 Mar 29.

16.

CD105 is important for angiogenesis: evidence and potential applications.

Duff SE, Li C, Garland JM, Kumar S.

FASEB J. 2003 Jun;17(9):984-92. Review.

PMID:
12773481
17.

Columnar cell lesions of the breast.

Schnitt SJ, Vincent-Salomon A.

Adv Anat Pathol. 2003 May;10(3):113-24. Review.

PMID:
12717115
18.
19.

Pseudoangiomatous stromal hyperplasia of the breast.

Castro CY, Whitman GJ, Sahin AA.

Am J Clin Oncol. 2002 Apr;25(2):213-6.

PMID:
11943906
20.

Supplemental Content

Support Center